PrePex has been developed as a means to scale-up Voluntary Medical Male Circumcision (VMMC) programs in Sub-Saharan African countries, providing a safe, simple and scalable solution to VMMC supply and demand challenges.
Therefore, we are happy to share with you news that Circ MedTech will offer the PrePex device at a reduced price for Sub-Saharan African VMMC priority countries that employ male circumcision programs as part of a comprehensive HIV prevention strategy.
Governments of the 14 priority countries, as identified by the World Health Organization (WHO), will now be able to procure the device at $12 USD per unit in accordance with the new Circ MedTech policy. The public health price – discounted from $20 USD per unit – is applicable to procurement of PrePex for VMMC implementation in Sub-Saharan African priority countries. We believe that by offering PrePex at a reduced price, national male circumcision programs can enhance scale-up efforts, reaching more citizens faster, while saving precious healthcare funds.
PrePex has been acknowledged by African governments as an effective means of scaling-up male circumcision programs and generating demand among men. In Rwanda, the Ministry of Health aims to circumcise 800,000 men by 2016, through a massive PrePex rollout. Zimbabwe’s Ministry of Health and Child Care recently included the PrePex device as an integral part of its national VMMC Action Plan with a target of circumcising 1.3 million men by 2018. South Africa and Uganda are in advanced stages of PrePex implementation, and have each set a goal of reaching more than four million men with male circumcision services. Other countries - such as Botswana, Kenya, Malawi, Zambia, Tanzania, Lesotho and Swaziland - are in varying phases of PrePex implementation.
Eddy Horowitz, Circ MedTech's CEO, said: "We are proud to demonstrate our commitment towards an AIDS-free generation together with our partners in the HIV/AIDS prevention field. Through this initiative we can prevent transmission of diseases, reduce costs to public health systems and save countless lives”.
Research conducted by the WHO has shown that male circumcision can reduce the spread of HIV and AIDS, together with other sexually-transmitted infections and cancer-causing viruses. Surgical circumcision procedures are generally costly, painful and time consuming. This is why we announced this initiative of providing PrePex - our innovative non-surgical device - for public healthcare programs.
The PrePex device is currently available for adult males and will be available for adolescent boys in the near future. In addition, Circ MedTech is in advanced stages of adapting PrePex technology for use in infants and children.
Mr. Horowitz added: "PrePex provides an easier, more convenient and cost-effective way of conducting male circumcision, both for patients and for healthcare providers. With our introduction of the non-surgical device for infants and children, PrePex will improve the male circumcision experience for men, boys and infants worldwide”.
We look forward to collaborating with you as we take VMMC programs
one-step forward towards an AIDS-Free Generation!
Watch the PrePex Champions share their experiences!